Hypothyroidism: An update

American Family Physician

Volumn 86, Issue 3, 2012, Pages 244-251

  Gaitonde, David Y ^a   Rowley, Kevin D ^a   Sweeney, Lori B ^a  

^a EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; COLESTIPOL; COLESTYRAMINE; CORTICOSTEROID; LEVOTHYROXINE; LIOTHYRONINE; LIOTHYRONINE SODIUM; PHENYTOIN; SERTRALINE; SUCRALFATE; TETRAHYDROLIPSTATIN; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; LIOTRIX;

ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL (TOPIC); COMA; DRUG DOSE INCREASE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HORMONAL THERAPY; HUMAN; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; MYXEDEMA; PREGNANT WOMAN; RISK FACTOR; SCREENING; THYROID FUNCTION TEST; AGE DISTRIBUTION; AUTOIMMUNE THYROIDITIS; CLINICAL FEATURE; DISEASE COURSE; HYPOPHYSIS; HYPOTHALAMUS; MASS SCREENING; OUTCOME ASSESSMENT; PREGNANCY; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; SYMPTOMATOLOGY; THYROID FUNCTION; THYROID GLAND; THYROTROPIN BLOOD LEVEL;

EID: 84864723159     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.
2. Boucai L, Hollowell JG, Surks MI. An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid. 2011;21(1):5-11.
3. Helfand M; U.S. Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(2):128-141.
4. Singer PA. Thyroiditis. Acute, subacute, and chronic. Med Clin North Am. 1991;75(1):61-77.
5. Devdhar M, Ousman YH, Burman KD. Hypothyroidism. Endocrinol Metab Clin North Am. 2007;36(3):595-615, v.
6. Barbesino G. Drugs affecting thyroid function. Thyroid. 2010;20(7):763-770.
7. Pérez López G, Carrasco De La Fuente M, Menacho Román M, González Albarrán O, Cano Megías M. Management of hypothyroidism secondary to tyrosine kinase inhibitors: description of treatment in three distinct clinical settings [in Spanish]. Endocrinol Nutr. 2011;58(2):94-96.
8. Wiersinga WM. Thyroid disease manager. Adult hypothyroidism. http://www.thyroidmanager.org/chapter/adult-hypothyroidism. Accessed January 12, 2012.
9. Dutta P, Bhansali A, Masoodi SR, Bhadada S, Sharma N, Rajput R. Predictors of outcome in myxoedema coma: a study from a tertiary care centre. Crit Care. 2008;12(1):R1.
10. Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction [published correction appears in Arch Intern Med. 2001;161(2):284]. Arch Intern Med. 2000;160(11):1573-1575.
11. American Academy of Family Physicians. Recommendations for thyroid screening. http://www.aafp.org/online/en/home/clinical/exam/thyroid.html. Accessed January 12, 2012.
12. Spencer CA. Clinical utility and cost-effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients. Mayo Clin Proc. 1988;63(12):1214-1222.
13. Levy EG, Ridgway EC, Wartofsky L. Algorithms for diagnosis and management of thyroid disorders. http://www.thyroidtoday.com/ExpertOpinions/ThyroidDiseaseAlgorithms.pdf. Accessed February 1, 2012.
14. Baskin HJ, Cobin RH, Duick DS, et al.; American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism [published correction appears in Endocr Pract. 2008;14(6):802-803]. Endocr Pract. 2002;8(6):457-469.
15. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228-238.
16. Roelfsema F, Pereira AM, Veldhuis JD, et al. Thyrotropin secretion profiles are not different in men and women. J Clin Endocrinol Metab. 2009;94(10):3964-3967.
17. Soldin SJ, Soukhova N, Janicic N, Jonklaas J, Soldin OP. The measurement of free thyroxine by isotope dilution tandem mass spectrometry. Clin Chim Acta. 2005;358(1-2):113-118.
18. Carle A, Laurberg P, Pedersen IB, et al. Epidemiology of subtypes of hypothyroidism in Denmark. Eur J Endocrinol. 2006;154(1):21-28.
19. Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA. 1995;273(10):808-812.
20. Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology. BMJ. 1996;313(7056):539-544.
21. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351(3):241-249.
22. Cooper DS, Ladenson PW. The thyroid gland. In: Gardner DG, Shoback D, eds. Greenspan's Basic and Clinical Endocrinology. 9th ed. New York, NY: McGraw Hill; 2011. http://www.accessmedicine.com/content.aspx?aID=8401830 (subscription required). Accessed April 30, 2012.
23. Wartofsky L. Levothyroxine therapy for hypothyroidism: should we abandon conservative dosage titration? Arch Intern Med. 2005;165(15):1683-1684.
24. Synthroid (levothyroxine sodium tablets, USP) [package insert]. North Chicago, Ill.: Abbott Laboratories. http://www.rxabbott.com/pdf/Synthroid.pdf. Accessed January 27, 2012.
25. American Association of Clinical Endocrinologists. AACE, TES, and ATA joint position statement on the use and interchangeability of thyroxine products. http://www.aace.com/files/AACE-TES-ATA-ThyroxineProducts.pdf. Accessed January 12, 2012.
26. Roos A, Linn-Rasker SP, van Domburg RT, Tijssen SP, Berghout A. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med. 2005;165(15):1714-1720.
27. Bolk N, Visser TJ, Nijman J, Jongste IJ, Tijssen JG, Berghout A. Effects of evening vs. morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010;170(22):1996-2003.
28. Grebe SK, Cooke RR, Ford HC, et al. Treatment of hypothyroidism with once weekly thyroxine. J Clin Endocrinol Metab. 1997;82(3):870-875.
29. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2006;91(7):2592-2599.
30. Panicker V, Saravanan P, Vaidya B, et al. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab. 2009;94(5):1623-1629.
31. McCowen KC, Garber JR, Spark R. Elevated serum thyrotropin in thyroxine-treated patients with hypothyroidism given sertraline. N Engl J Med. 1997;337(14):1010-1011.
32. Díez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004;89(10):4890-4897.
33. Wartofsky L. Myxedema coma. Endocrinol Metab Clin North Am. 2006;35(4):687-698, vii-viii.